Skip to content
← Full study record

NCT00027560 · MORE INFO

Limitations, agreements, and source contact

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer · Source last updated 2013-01-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
castro-h@mskcc.org
organization
Memorial Sloan-Kettering Cancer Center
phone
212-639-8197
title
Dr. Hugo Castro-Malaspina
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
castro-h@mskcc.org
organization
Memorial Sloan-Kettering Cancer Center
phone
212-639-8197
title
Dr. Hugo Castro-Malaspina

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice